Equities analysts expect Tilray Inc (NASDAQ:TLRY) to post ($0.23) earnings per share for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Tilray’s earnings, with the highest EPS estimate coming in at ($0.12) and the lowest estimate coming in at ($0.35). Tilray reported earnings of ($0.17) per share during the same quarter last year, which suggests a negative year over year growth rate of 35.3%. The business is expected to report its next quarterly earnings report on Tuesday, August 27th.
On average, analysts expect that Tilray will report full-year earnings of ($0.89) per share for the current year, with EPS estimates ranging from ($1.38) to ($0.42). For the next fiscal year, analysts forecast that the firm will post earnings of ($0.35) per share, with EPS estimates ranging from ($1.05) to $0.24. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow Tilray.
Tilray (NASDAQ:TLRY) last released its earnings results on Tuesday, May 14th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.02). The firm had revenue of $23.00 million during the quarter, compared to analysts’ expectations of $20.50 million. Tilray had a negative return on equity of 43.71% and a negative net margin of 159.09%. Tilray’s quarterly revenue was up 194.9% compared to the same quarter last year.
Several research firms have recently weighed in on TLRY. Piper Jaffray Companies dropped their target price on shares of Tilray from $84.00 to $72.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 15th. Jefferies Financial Group lifted their target price on shares of Monster Beverage from $65.00 to $70.00 and gave the stock a “buy” rating in a research report on Friday, May 3rd. Oppenheimer began coverage on shares of Tilray in a research report on Tuesday, June 4th. They issued a “market perform” rating on the stock. Compass Point dropped their target price on shares of Tilray from $41.00 to $38.00 and set a “sell” rating on the stock in a research report on Monday, June 17th. Finally, Vertical Group began coverage on shares of Tilray in a research report on Friday, April 12th. They issued a “sell” rating on the stock. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $76.97.
Shares of Tilray stock traded up $0.18 during trading on Friday, hitting $43.59. The stock had a trading volume of 1,184,095 shares, compared to its average volume of 2,067,950. The stock’s 50 day simple moving average is $43.40. The stock has a market cap of $4.25 billion and a P/E ratio of -53.16. The company has a quick ratio of 2.06, a current ratio of 2.35 and a debt-to-equity ratio of 1.13. Tilray has a 1 year low of $21.50 and a 1 year high of $300.00.
In related news, Director Christine St.Clare sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $50.01, for a total transaction of $200,040.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 3.40% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the stock. California Public Employees Retirement System grew its position in Tilray by 247.4% during the fourth quarter. California Public Employees Retirement System now owns 5,617 shares of the company’s stock valued at $396,000 after purchasing an additional 4,000 shares in the last quarter. Regal Investment Advisors LLC purchased a new position in Tilray during the first quarter valued at approximately $201,000. Millennium Management LLC lifted its stake in Tilray by 255.6% in the fourth quarter. Millennium Management LLC now owns 8,402 shares of the company’s stock valued at $593,000 after acquiring an additional 6,039 shares during the last quarter. Hellman Jordan Management Co. Inc. MA acquired a new stake in Tilray in the first quarter valued at approximately $3,276,000. Finally, Commonwealth Equity Services LLC lifted its stake in Tilray by 132.7% in the fourth quarter. Commonwealth Equity Services LLC now owns 8,395 shares of the company’s stock valued at $592,000 after acquiring an additional 4,788 shares during the last quarter. 2.10% of the stock is currently owned by hedge funds and other institutional investors.
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More: What does an equal weight rating mean?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.